Natera
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2004-01-01
- Employees
- 3K
- Market Cap
- -
- Website
- http://www.natera.com
- Introduction
Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in Austin, TX.
Multi-disease Carrier Screening Test Validation
- Conditions
- Spinal Muscular Atrophy (SMA)Genetic TestingCarrier Screening
- First Posted Date
- 2012-08-13
- Last Posted Date
- 2013-07-16
- Lead Sponsor
- Natera, Inc.
- Registration Number
- NCT01663584
- Locations
- 🇺🇸
Natera, Inc, San Carlos, California, United States
Non-invasive Prenatal Diagnostic Validation Study
- Conditions
- Chromosome 21 AneuploidyChromosome 18 AneuploidySex Chromosome AberrationsOther MicrodeletionsChromosome 13 Aneuploidy
- Interventions
- Procedure: Blood drawProcedure: Cheek swab/Saliva Sampling
- First Posted Date
- 2012-04-10
- Last Posted Date
- 2013-07-02
- Lead Sponsor
- Natera, Inc.
- Target Recruit Count
- 1781
- Registration Number
- NCT01574781
- Locations
- 🇺🇸
Natera, Inc, Redwood City, California, United States
Collection of Maternal Blood Samples for Development of Non-invasive Prenatal Diagnostic Testing
- Conditions
- Pregnancy Following IVF With PGS/PGD
- Interventions
- Procedure: Blood draw
- First Posted Date
- 2012-03-07
- Last Posted Date
- 2013-08-12
- Lead Sponsor
- Natera, Inc.
- Target Recruit Count
- 16
- Registration Number
- NCT01546324
- Locations
- 🇺🇸
Natera, Inc, Redwood City, California, United States
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
- Conditions
- Trisomy 18Trisomy 13Trisomy 21Aneuploidy
- Interventions
- Procedure: Blood Draw
- First Posted Date
- 2012-03-07
- Last Posted Date
- 2023-03-23
- Lead Sponsor
- Natera, Inc.
- Target Recruit Count
- 937
- Registration Number
- NCT01545674
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸New York University, New York, New York, United States
🇺🇸Adventist Hinsdale Hospital, Hinsdale, Illinois, United States
Clinical Use of Parental Support To Detect Single Gene Mutations
- Conditions
- Single Gene Disorders
- First Posted Date
- 2010-09-09
- Last Posted Date
- 2013-07-16
- Lead Sponsor
- Natera, Inc.
- Target Recruit Count
- 240
- Registration Number
- NCT01197872
- Locations
- 🇺🇸
Gene Security Network, Redwood City, California, United States
Impact of Parental Support on Pregnancy Outcomes (IPSO) Trial- Day 3 Preimplantation Genetic Screening (PGS) With Day 5 Fresh Transfer
- Conditions
- Preimplantation Gentic Screening (PGS)In Vitro Fertilization (IVF)Preimplantation Genetic Diagnosis (PGD)
- Interventions
- Device: 24 Chromosome Aneuploidy Screening with Parental Support
- First Posted Date
- 2010-09-03
- Last Posted Date
- 2014-11-25
- Lead Sponsor
- Natera, Inc.
- Target Recruit Count
- 59
- Registration Number
- NCT01194531
- Locations
- 🇺🇸
Shady Grove Fertility RSC, Washington, District of Columbia, United States
🇺🇸Huntington Reproductive Center, Laguna Hills, California, United States
🇺🇸Florida Fertility Institute/ Women's Medical Research Group, LLC, Clearwater, Florida, United States
Concurrent Single Gene and 24 Chromosome Aneuploidy Preimplantation Genetic Diagnosis (PGD)
- Conditions
- Any Single Gene Disorder (Cystic Fibrosis, Tay-Sachs)
- Interventions
- Other: preimplantation diagnosis
- First Posted Date
- 2009-12-02
- Last Posted Date
- 2014-04-02
- Lead Sponsor
- Natera, Inc.
- Target Recruit Count
- 56
- Registration Number
- NCT01023048
- Locations
- 🇺🇸
Gene Security Network, Redwood City, California, United States